drugset / Trial / NCT00053846
Buspirone in Reducing Shortness of Breath in Patients With Cancer
RandomizedParallel-groupDouble-blindSupportive care
Summary
RATIONALE: Buspirone may be effective in reducing dyspnea (shortness of breath) in patients with cancer who are undergoing chemotherapy. PURPOSE: Randomized clinical trial to study the effectiveness of buspirone in reducing shortness of breath in patients who are undergoing chemotherapy for cancer.
Timeline
- Start
- 2002-11
- Primary completion
- 2010-11
- Completion
- 2011-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Buspirone | Small molecule | 10 mg | Oral |